Alterations of glycosidases in human colonic adenocarcinoma

被引:15
作者
GilMartin, E
RodriguezBerrocal, J
DelaCadena, MP
FernandezBriera, A
机构
[1] Department of Fundamental Biology, Area of Biochem. and Molec. Biology, University of Vigo, Vigo
[2] Area of Biochem. and Molec. Biology, Faculty of Sciences (Biology), University of Vigo, Vigo
关键词
glycosidases; human; colon; adenocarcinoma;
D O I
10.1016/S0009-9120(96)00123-3
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: We have carried out a detailed study of some glycosidases in an attempt to explain the differential profile of enzyme activity between human colonic adenocarcinoma and normal mucosa. Design and Methods: Several glycosidase activities associated with human colonic adenocarcinoma and control tissues were submitted to a detailed structural and functional characterization. Results: Tumoral and control samples were assayed for beta-D-galactosidase, beta-D-glucuronidase, alpha-D-mannosidase, beta-NAc-D-glucosaminidase and beta-NAc-D-galactosaminidase activities. Tumoral tissue showed higher beta-D-galactosidase, beta-NAc-D-glucosaminidase, and beta-NAc-D-galactosaminidase activities than control tissue. Glycosidases from tumoral and control tissues demonstrated no differences in optimum pH, subcellular distribution, pH and thermal stability. However, the kinetic analysis showed a statistically significant increased V-max in tumoral colon with respect to the control for beta-D-galactosidase, beta-NAc-D-glucosaminidase, and beta-NAc-D-galactosaminidase activities. The K-m remained unaltered. Conclusions: The increased V-max detected for some glycosidase activities in human colonic adenocarcinoma could correspond with a greater presence of enzyme proteins in the tumoral cells, and not to changes in protein and/or active site structure.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 34 条
[1]  
ALHADEFF JA, 1989, CRIT REV ONCOL HEMAT, V9, P39
[2]  
ALHADEFF JA, 1977, PRACTICAL ENZYMOLOGY, P247
[3]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[4]   CORRELATION OF LYSOSOMAL-ENZYME ABNORMALITIES IN VARIOUS FORMS OF ADULT LEUKEMIA [J].
BESLEY, GTN ;
MOSS, SE ;
BAIN, AD ;
DEWAR, AE .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (09) :1000-1004
[5]   DESCRIPTIVE EPIDEMIOLOGY OF COLORECTAL-CANCER [J].
BOYLE, P ;
ZARIDZE, DG ;
SMANS, M .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (01) :9-18
[6]  
CHATTERJEE SK, 1982, CANCER, V49, P128, DOI 10.1002/1097-0142(19820101)49:1<128::AID-CNCR2820490124>3.0.CO
[7]  
2-T
[8]  
DANO K, 1985, ANTICANCER RES, V5, P605
[9]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[10]  
DOBROSSY L, 1980, CANCER RES, V40, P3281